An early experience with Simulect (basiliximab): an IL-2 receptor antibody

Transplant Proc. 2000 Nov;32(7):1739-40. doi: 10.1016/s0041-1345(00)01394-4.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / therapeutic use
  • Basiliximab
  • Cyclosporine / therapeutic use
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / surgery
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / immunology*
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Prednisolone / therapeutic use
  • Receptors, Interleukin-2 / antagonists & inhibitors
  • Recombinant Fusion Proteins*
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab
  • Prednisolone
  • Azathioprine
  • Methylprednisolone